Navigation Links
Simplifying manufacture of drugs, plastics earns UH chemist top honor
Date:3/25/2008

HOUSTON, March 24, 2008 Simplifying the process for forming compounds that can be used in many everyday products, such as pharmaceuticals and plastics, has earned one University of Houston chemist a prestigious honor.

Olafs Daugulis, assistant professor of chemistry in the College of Natural Sciences and Mathematics at UH, is among 118 outstanding young scientists, mathematicians and economists in the United States and Canada to be named an Alfred P. Sloan Research Fellow for 2008. This distinction is bestowed upon exceptional researchers early in their academic careers. Thirty-five of these fellows have gone on to win the Nobel Prize since the Sloan Foundation first began these awards in 1955.

Daugulis developed a simplified technique that saves time and labor, produces less waste and reduces costs while making compounds potentially useful for manufacturing pharmaceuticals and plastics. To make such products, chemists begin with natural compounds, such as oil, that have a single bond between carbon and hydrogen atoms. Chemists must then convert this to another type known as a carbon-carbon bond to create the end product. This has involved a number of intervening steps due to the lack of a direct method of conversion. Daugulis research has changed this.

We are taking a carbon-hydrogen bond and converting it directly to a carbon-carbon bond without going through an intermediate step, Daugulis said. This means fewer synthetic steps in getting to what you want to make. Instead of two to five steps, we are doing it in one.

Carbon-carbon bonding is widely used in the manufacture of pharmaceuticals, but Daugulis is one of only a few scientists using direct carbon-hydrogen to carbon-carbon bonding. His method incorporates a metallic complex composed of palladium, and most recently copper, as a catalyst.

While Daugulis modesty keeps him from assuming there is a Nobel Prize in his future, one Nobel l
'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Page: 1 2

Related biology news :

1. UT researcher earns $1.3M grant to study toxic cleanup at DOD sites
2. Computer learns dogspeak
3. Clemson chemists discover new way antioxidants fight debilitating diseases
4. Computational actinide chemistry: Are we there yet?
5. Chemists get grip on slippery lipids
6. American Chemical Society calls green chemistry bill a smart step
7. Using green chemistry to deliver cutting-edge drugs
8. Good earth: Brown chemists show origin of soil-scented geosmin
9. Penn biochemist receives NIH New Innovators Award
10. Chemistry turns killer gas into potential cure
11. K-State chemistry professor to receive Masao Horiba award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Simplifying manufacture of drugs, plastics earns UH chemist top honor
(Date:8/12/2015)... YORK , Aug. 12, 2015  New ... hackers can attack Android phones to steal users, ... the increasing availability of fingerprint scanners on mobile ... utmost concern. To secure biometrics on mobile devices, ... to augment these convenient authentication systems with strong ...
(Date:8/10/2015)... The latest 364 page report from ... the global border security market . Visiongain ... 2015. Now: Border security is hard to achieve ... business critical issue you need to know about - and ... analysis of how this will impact your company and the ...
(Date:8/5/2015)... According to a new market research report, ... (BFSI, Airport, IT & Telecom, Utilities, Education, Defense & ... published by MarketsandMarkets, defines and segments the Physical Identity ... global PIAM Market is estimated to grow from $272.2 ... a CAGR of 14.9 % from 2014 to 2019. ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... Leave it to geneticists to answer a question that has ... first sight truly exist? According to a study published in ... ( http://www.genetics.org ), a team of scientists from the United ... males and females are more compatible than others, and that ...
... ANN ARBOR, Mich.---Scientists at the University of Michigan ... appears safe for regenerating tooth-supporting gum tissue---a discovery ... surrounding gene therapy research and tissue engineering. ... concept, but safety is a major hurdle, said ...
... as the next best source for fueling the ,world,s ... creating biofuels ,from algae is that when you extract ... dramatically raising production costs. Now researchers at the U.S. ... have ,developed groundbreaking "nanofarming" technology that safely harvests oil ...
Cached Biology News:Is love at first sight real? Geneticists offer tantalizing clues 2Gene therapy appears safe to regenerate gum tissue 2Nanofarming technology harvest biofuel oils without harming algae 2
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... CUMBERLAND, R.I. , Sept. 2, 2015 /PRNewswire/ ... has been enrolled in the multicenter Phase 2 ... for the long-term treatment of recurrent subfoveal choroidal ... AMD).  NT-503 is a unique vascular endothelial growth ... versatile ECT implant. "This landmark proof-of-concept ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 ... BVXV) today announced the intent of the National Institute of ... Institutes of Health (NIH) within the Department of Health and ... to be held in the United States ... use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... creating professional commercial video content, to analysis of athletic performance. Producing high-resolution ... go by too quickly to process with the naked eye. , Slow ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... SAN DIEGO, Aug. 25 NexBio, Inc. announced today ... Human Lung Tissues" in the September, 2009 issue of the ... DAS181 (Fludase ((R)) ) is an investigational drug ... (e.g. Tamiflu ((R)) ), which target the virus, DAS181 works ...
... 25 Peptimmune, Inc., a privately held biotechnology company, ... the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in ... is a novel peptide copolymer for the treatment of ... The Phase Ib multiple-ascending dose, double-blind, placebo-controlled, ...
... - Medicago Inc. (TSX-V: MDG) a biotechnology company ... based on proprietary manufacturing technologies and Virus-Like Particles ... from Health Canada to commence a Phase I ... vaccine ("H5N1 vaccine"). Enrollment of volunteers is now ...
Cached Biology Technology:NexBio(R) Demonstrates DAS181 (Fludase(R)*), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue 2NexBio(R) Demonstrates DAS181 (Fludase(R)*), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue 3NexBio(R) Demonstrates DAS181 (Fludase(R)*), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue 4Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009 2Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009 3Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine 2Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine 3
...
... PCRx Enhancer System is used ... to optimize PCR of problematic ... PCRX Enhancer Solution with 10X ... primer specificity broader magnesium concentration ...
Mouse Exodus 2 - 12kDa...
Laminin gamma-2 (G-16)...
Biology Products: